Obstructive hydrocephalus secondary to an anterior mesencephalic cavernous malformation with familial cerebral cavernous malformation syndrome: A case report.

Transient Dysphagia as a Presenting Symptom of Familial Cerebral Cavernous Malformation.

Natural history of familial cerebral cavernous malformations: the CCM_Italia cohort study.

Familial Cerebral Cavernous Malformations: Pathophysiology, Genetics, Biomarkers, and Treatment Perspectives.

Late-onset familial cerebral cavernous malformation without a family history: a case description.

Familial cerebral cavernous malformations caused by a novel germline structural variant in the KRIT1 gene.

Association of Quality of Life Domains and Clinical Symptoms in Patients With Familial Cerebral Cavernous Malformation.

Familial Cerebral Cavernous Malformations : A Clinical Series and Literature Review.

Lifetime Risk of First Symptomatic ICH or Seizure in Familial Cerebral Cavernous Malformations: A Multicenter Patient Data Analysis.

Improving genetic diagnostic yield in familial and sporadic cerebral cavernous malformations: detection of copy number and deep Intronic variants.

Comparative Analysis of the Health-Related Quality of Life Between Patients with Familial and Sporadic Forms of Cerebral Cavernous Malformation.

Plasma biomarkers in patients with familial cavernous malformation and their first-degree relatives: a cross-sectional study.

Innovative Quantitative Analysis for Disease Progression Assessment in Familial Cerebral Cavernous Malformations.

Management of Maternal Genetic Conditions in Pregnancy, Part 1: Disorders of the Connective Tissue, Muscle, Vascular, and Skeletal Systems.

Clinical and radiologic distinctions between familial cavernous malformation syndrome and cerebral amyloid angiopathy.

Clinical features, hemorrhage risk and epilepsy outcomes of familial cerebral cavernous malformation: A 20-year observational pragmatic single-center study.

Commentary on "Tobacco use increases lesion burden in familial cerebral cavernous malformation syndrome".

Teaching NeuroImage: Familial Cerebral Cavernous Malformation in PDCD10 Genotype.

Tobacco use increases lesion burden in familial cerebral cavernous malformation syndrome.

Prevalence, genetic and clinical characteristics in first-degree relatives of patients with familial cerebral cavernous malformations in China.

Genotype-phenotype correlations in multiple lesions of familial cerebral cavernous malformations concerning phosphatidylinositol 3-kinase catalytic subunit alpha mutations.

Patient-reported outcome measures in patients with familial cerebral cavernous malformations: results from the Treat_CCM trial.

Novel Development of a Large Cerebral Cavernous Malformation in an Adolescent With a History of Familial Cerebral Cavernous Malformation Syndrome.

Familial cerebral cavernous malformation presenting with cerebellopontine angle syndrome in a patient with autosomal dominant polycystic kidney disease.

Contralateral Interhemispheric Transfalcine Approach to the Basal Ganglia.

Circulating biomarkers in familial cerebral cavernous malformation.

Clinical characteristics of familial and sporadic pediatric cerebral cavernous malformations and outcomes.

Towards a neurocognitive profile in familial cerebral cavernous malformations.

A tangled web: Dual diagnosis of hereditary hemorrhagic telangiectasia and familial cerebral cavernous malformation.

Molecular genetic features and clinical manifestations in Chinese familial cerebral cavernous malformation: from a novel KRIT1/CCM1 mutation (c.1119dupT) to an overall view.

Amplification of protease-activated receptors signaling in sporadic cerebral cavernous malformation endothelial cells.

A novel KRIT1/CCM1 mutation accompanied by a NOTCH3 mutation in a Chinese family with multiple cerebral cavernous malformations.

Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation.

Clinicoradiologic data of familial cerebral cavernous malformation with age-related disease burden.

Magnetic susceptibility as a 1-year predictor of outcome in familial cerebral cavernous malformations: a pilot study.

Monogenic Causes in Familial Stroke Across Intracerebral Hemorrhage and Ischemic Stroke Subtypes Identified by Whole-Exome Sequencing.

Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial.

Natural history of familial cerebral cavernous malformation syndrome in children: a multicenter cohort study.

Identification of a novel LATS1 variant associated with familial cerebral cavernous malformations in a Chinese family.

Transcriptome Analysis Reveals Altered Expression of Genes Involved in Hypoxia, Inflammation and Immune Regulation in Pdcd10-Depleted Mouse Endothelial Cells.

Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease.

Spinal involvement in pediatric familial cavernous malformation syndrome.

A Chinese Family With Cerebral Cavernous Malformation Caused by a Frameshift Mutation of the CCM1 Gene: A Case Report and Review of the Literature.

Primary Delayed Onset Craniosynostosis in a Child With ERF-Related Craniosynostosis Syndrome and Familial Cerebral Cavernous Malformation Syndrome.

Medication intake and hemorrhage risk in patients with familial cerebral cavernous malformations.

De novo brain AVM following radiotherapy for cerebral cavernous malformation in a child: A 15-year clinical course.

Multiple cerebral cavernous malformations: Clinical course of confirmed, assumed and non-familial disease.

Familial Cerebral Cavernous Malformation Mimicking Cerebral Amyloid Angiopathy.

A Midsummer Night's Gene: The familial Neurological Illness of Felix Mendelssohn.

Description of Two Families with New Mutations in Familial Cerebral Cavernous Malformations Genes.

Fetal Familial Cerebral Cavernous Malformation With a Novel Heterozygous KRIT1 Variation.

Assessing the association of common genetic variants in EPHB4 and RASA1 with phenotype severity in familial cerebral cavernous malformation.

Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations.

Seizure Incidence Rates in Children and Adults With Familial Cerebral Cavernous Malformations.

Feasibility and Morbidity of Magnetic Resonance Imaging-Guided Stereotactic Laser Ablation of Deep Cerebral Cavernous Malformations: A Report of 4 Cases.

Asymptomatic Familial Multiple Cerebral Cavernous Malformation in a 73-Year-Old Woman.

Lingual Seizures Due to Familial Cerebral Cavernous Malformations.

Novel COL4A2 mutation causing familial malformations of cortical development.

A Novel CCM2 Missense Variant Caused Cerebral Cavernous Malformations in a Chinese Family.

Familial cerebral cavernous malformation presenting with epilepsy caused by mutation in the CCM2 gene: A case report.

First Report of Concomitant Pathogenic Mutations Within MGC4607/CCM2 and KRIT1/CCM1 in a Familial Cerebral Cavernous Malformation Patient.

Genome-wide Genotyping of Cerebral Cavernous Malformation Type 1 Individuals to Identify Genetic Modifiers of Disease Severity.

Next Generation Sequencing (NGS) Strategies for Genetic Testing of Cerebral Cavernous Malformation (CCM) Disease.

High Prevalence of Spinal Cord Cavernous Malformations in the Familial Cerebral Cavernous Malformations Type 1 Cohort.

Familial Cerebral Cavernous Malformation Syndrome with Concomitant Fourth Ventricular Ependymoma: True Association or Mere Coincidence?

Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial.

Concern regarding classification of c.703G>A/p.Gly235Arg as a novel missense variant in KRIT1 gene.

Stereotactic laser interstitial thermal therapy for epilepsy associated with solitary and multiple cerebral cavernous malformations.

A British family with familial cerebral cavernous malformation due to a rare mutation of the CCM2 gene.

Novel CCM1 (KRIT1) Mutation Detection in Brazilian Familial Cerebral Cavernous Malformation: Different Genetic Variants in Inflammation, Oxidative Stress, and Drug Metabolism Genes Affect Disease Aggressiveness.

Cutaneous findings of familial cerebral cavernous malformation syndrome due to the common Hispanic mutation.

Vertebral Intraosseous Vascular Malformations in a Familial Cerebral Cavernous Malformation Population: Prevalence, Histologic Features, and Associations With CNS Disease.

Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation.

Cerebral cavernous malformation type 1 with retinal blood vessel tortuosity and KRIT1 gene mutation.

"Radiologically Isolated" Spinal Cavernoma Associated with Familial Cerebral Cavernomatosis.

Molecular diagnostic workflow, clinical interpretation of sequence variants, and data repository procedures in 140 individuals with familial cerebral cavernous malformations.

Familial Cerebral Cavernous Malformations.

Familial Cavernous Hemangioma.

Two Novel CCM2 Heterozygous Mutations Associated with Cerebral Cavernous Malformation in a Chinese Family.

Suboccipital Craniotomy for Resection of a Dorsal Medullary Cerebral Cavernous Malformation: 2-Dimensional Operative Video.

A new heterozygous G duplicate in exon1 (c.100dupG) of gelsolin gene causes Finnish gelsolin amyloidosis in a Chinese family.

A novel large deletion in CCM1 gene in a Tunisian family.

Management of brothers with haemophilia A and familial cerebral cavernous malformations.

Connexin 43 gap junctions contribute to brain endothelial barrier hyperpermeability in familial cerebral cavernous malformations type III by modulating tight junction structure.

First large genomic inversion in familial cerebral cavernous malformation identified by whole genome sequencing.

A novel CCM1/KRIT1 heterozygous deletion mutation (c.1919delT) in a Chinese family with familial cerebral cavernous malformation.

Familial cerebral cavernous malformation: Report of a novel KRIT1 mutation in a Portuguese family.

Hereditary Multiple Cerebral Cavernous Malformations Associated with Wilson Disease and Multiple Lipomatosis.

Automated algorithm for counting microbleeds in patients with familial cerebral cavernous malformations.

Familial Cerebral Cavernous Malformations Are Associated with Adrenal Calcifications on CT Scans: An Imaging Biomarker for a Hereditary Cerebrovascular Condition.

A Novel CCM1/KRIT1 Heterozygous Nonsense Mutation (c.1864C>T) Associated with Familial Cerebral Cavernous Malformation: a Genetic Insight from an 8-Year Continuous Observational Study.

Ascending Spinal Cord Infarction Secondary to Recurrent Spinal Cord Cavernous Malformation Hemorrhage.

A Novel KRIT1/CCM1 Gene Insertion Mutation Associated with Cerebral Cavernous Malformations in a Chinese Family.

Review of familial cerebral cavernous malformations and report of seven additional families.

Genetically diagnosed Birt-Hogg-Dubé syndrome and familial cerebral cavernous malformations in the same individual: a case report.

A Novel CCM2 Gene Mutation Associated with Familial Cerebral Cavernous Malformation.

Identification of a Novel Deletion Mutation (c.1780delG) and a Novel Splice-Site Mutation (c.1412-1G>A) in the CCM1/KRIT1 Gene Associated with Familial Cerebral Cavernous Malformation in the Chinese Population.

Two cases of familial cerebral cavernous malformation caused by mutations in the CCM1 gene.

Familial Multiple Cavernous Malformation Syndrome: MR Features in This Uncommon but Silent Threat.

Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1.

Genetics of cerebral cavernous malformations: current status and future prospects.

Increased number of white matter lesions in patients with familial cerebral cavernous malformations.